Evaluation of benzyl selenocyanate glutathione conjugate for potential chemopreventive properties in colon carcinogenesis

International Journal of Oncology

Volumn 13, Issue 1, 1998, Pages 29-34

  Kawamori, Toshihiko ^a   El Bayoumy, Karam ^a   Ji, Ben Yi ^a   Rosa Rodriguez, Jose G ^a   Rao, Chinthalapally V ^a   Reddy, Bandaru S ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Aberrant crypt foci; Colon cancer; Cyclooxygenase; Glutathione S transferase; Organoselenium

Indexed keywords

AZOXYMETHANE; BENZYL SELENOCYANATE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; ORGANOSELENIUM DERIVATIVE; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CHEMOTHERAPY; COLON CARCINOGENESIS; DIET SUPPLEMENTATION; ENZYME ACTIVITY; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT;

EID: 0031835148     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.1.29     Document Type: Article

References (32)

1. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 47: 5-27, 1997.
2. Reddy BS: Diet and colon cancer: evidence from human and animal model studies. In: Diet, Nutrition and Cancer: A Critical Evaluation. Reddy BS and Cohen LA (eds). CRC Press, Boca Ranton, FL, pp47-65, 1986.
3. Clark LC, Cantor KP and Allaway WH: Selenium in forage crops and cancer mortality in U.S. counties. Arch Environ Health 46: 37-42, 1991.
4. Clark LC and Alberts DS: Selenium and cancer: risk or protection? J Natl Cancer Inst 87: 473-475, 1995.
5. Reddy BS, Sugie S, Maruyama H, El-Bayoumy K and Marra P: Chemoprevention of colon carcinogenesis by dietary organoselenium, benzylselenocyanate, in F344 rats. Cancer Res 47: 5901-5904, 1987.
6. Reddy BS, Rivenson A, Kulkarni N, Upadhyaya P and El-Bayoumy K: Chemoprevention of colon carcinogenesis by synthetic organoselenium compound, 1, 4- phenylenebis (methylene)selenocyanate. Cancer Res 52: 5635-5640, 1992.
7. Lanfear J, Fleming J, Wu L, Webster G and Harrison PR: The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 15: 1387-1392, 1994.
8. Hasegawa T, Okuno T, Nakamuro K and Sayato Y: Identification and metabolism of selenocysteine-glutathione selenenyl sulfide (CySeSG) in small intestine of mice orally exposed to selenocystine. Arch Toxicol 71: 39-44, 1996.
9. Bird RP: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37: 147-151, 1987.
10. McLellan EA and Bird RP: Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res 48: 6187-6192, 1988.
11. Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA and Stellato TA: Aberrant crypts: putative preneoplastic foci in human colonie mucosa. Cancer Res 51: 1564-1567, 1991.
12. Wargovich MJ, Chen C-D, Jimenez A, Steele VE, Velasco M, Stephens LC, Price R, Gray K and Kelloff GJ: Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 5: 355-360, 1996.
13. Vivona AA, Shpitz B, Medline A, Bruce WR, Hay K, Ward MA, Stern HS and Gallinger S: K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis 14: 1777-1781, 1993.
14. Kawamori T, Tanaka T, Ohnishi M, Hirose Y, Nakamura Y, Satoh K, Hara A and Mori H: Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding s-methyl methane thiosulfonate in male F344 rats. Cancer Res 55: 4053-4058, 1995.
15. Reddy BS, Rao CV and Seibert K: Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56: 4566-4569, 1996.
16. Kawamori T, Rao CV, Seibert K and Reddy BS: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58: 409-412, 1998.
17. El-Bayoumy K, Upadhyaya P, Chae Y-H, Sohn OS, Rao CV, Fiala ES and Reddy BS: Chemoprevention of cancer by organo-selenium compounds. J Cell Biochem 22: 92-100, 1995.
18. Jakoby WB: The glutathione S-transferases: a group of multifunctional detoxification proteins. Adv Enzymol Relat Areas Mol Biol 46: 383-414, 1978.
19. Mannervik B: The isozymes of glutathione transferase. Adv Enzymol Relat Areas Mol Biol 57: 357-417, 1985.
20. Mannervik B, Ålin P, Guthenberg C, Jensson H, Tahir MK, Warholm M and Jörnvall H: Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 82: 7202-7206, 1985.
21. Seidegård J, Pero RW, Markowitz MM, Roush G, Miller DG and Beattie EJ: Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis 11: 33-36, 1990.
22. Lafuente A, Pujol F, Carretero P, Villa JP and Cuchi A: Human glutathione S-transferase μ (GST-μ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 68: 49-54, 1993.
23. Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, Moore DF, Litwin S, Goosenberg EB, Frucht H, Engstrom PF and Clapper ML: Glutathione S-transferase activity and glutathione S-transferase μ expression in subjects with risk for colorectal cancer. Cancer Res 55: 2789-2793, 1995.
24. Clapper ML, Hoffman SJ and Tew KD: Glutathione S-transferases in normal and malignant human colon tissue. Biochim Biophys Acta 1096: 209-216, 1991.
25. Ranganathan S and Tew KD: Immunohistochemical localization of glutathione S-transferases α, μ and π in normal tissue and carcinomas from human colon. Carcinogenesis 12: 2383-2387, 1991.
26. Kuo C-F, Cheng S and Burgess JR: Deficiency of vitamin E and selenium enhances calcium-independent phospholipase A2 activity in rat lung and liver. J Nutr 1419-1429, 1995.
27. El-Bayoumy K: Effects of organoselenium compounds on induction of mouse forestomach tumors by benzo(a)pyrene. Cancer Res 45: 3631-3635, 1985.
28. Rao CV, Rivenson A, Simi B and Reddy BS: Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55: 259-266, 1995.
29. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
30. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
31. Zhang X-M, Stamp D, Minkin S, Medline A, Corpet DE, Bruce WR and Archer MC: Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein. J Natl Cancer Inst 84: 1026-1030, 1992.
32. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC and Seibert K: Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91: 3228-3232, 1994.